Log in
Enquire now
‌

US Patent 11945801 Bicyclic aza compounds as muscarinic M

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Date Filed
December 9, 2019
0
Date of Patent
April 2, 2024
0
Patent Applicant
‌
Heptares Therapeutics
0
Patent Application Number
17311121
0
Patent Citations
‌
US Patent 8119661 Piperidine derivatives and their use as muscarinic receptor modulators
0
‌
US Patent 8476289 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylace
0
‌
US Patent 9067951 Process and intermediates for the production of CCR2 antagonists
0
‌
US Patent 9187451 Muscarinic M1 receptor agonists
0
‌
US Patent 9266857 Bicyclic AZA compounds as muscarinic M1 receptor agonists
0
‌
US Patent 9573929 Muscarinic M1 receptor agonists
0
‌
US Patent 9593106 Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists
0
‌
US Patent 7067507 Macrocycles useful in the treatment of Alzheimer's disease
0
‌
US Patent 7163938 Substituted carboxamides
0
‌
US Patent 7524852 Bicyclic pyrimidine derivatives
0
•••
Patent Inventor Names
Giles Albert Brown
0
Benjamin Gerald Tehan
0
Barry John Teobald
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11945801
0
Patent Primary Examiner
‌
Laura L. Stockton
0
CPC Code
‌
C07D 451/02
0
‌
C07D 413/04
0
‌
C07D 451/14
0
‌
C07D 403/04
0
‌
C07D 403/14
0

Find more entities like US Patent 11945801 Bicyclic aza compounds as muscarinic M

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.